Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1301
Geron
GERN
$790M
| $7.05M | 0.01% |
4,999,100
-602,000
| -11% | -$853K |
2024 Q4
2 quarters
|
|
1302
Zurn Elkay Water Solutions
ZWS
$7.72B
| $7.04M | 0.01% |
192,493
+2,900
| +2% | +$99.8K |
2022 Q4
10 quarters
|
|
1303
Clarivate
CLVT
$1.03B
| $7.04M | 0.01% |
1,636,400
+706,400
| +76% | +$2.85M |
2025 Q1
1 quarter
|
|
1304
Cohen & Steers
CNS
$3.56B
| $7.02M | 0.01% |
93,112
+60,500
| +186% | +$4.65M |
2024 Q2
4 quarters
|
|
1305
Lifestance Health
LFST
$4.72B
| $6.99M | 0.01% |
1,352,100
+189,000
| +16% | +$1.13M |
2024 Q1
5 quarters
|
|
1306
BK Technologies
BKTI
$277M
| $6.99M | 0.01% |
148,269
+32,799
| +28% | +$1.47M |
2013 Q2
48 quarters
|
|
1307
Carter's
CRI
$1.19B
| $6.98M | 0.01% |
231,700
+190,800
| +467% | +$6.47M |
2025 Q1
1 quarter
|
|
1308
Invesco
IVZ
$13B
| $6.98M | 0.01% |
442,600
+288,700
| +188% | +$4.15M |
2023 Q4
6 quarters
|
|
1309
Sonic Automotive
SAH
$1.91B
| $6.98M | 0.01% |
87,300
+2,200
| +3% | +$148K |
2023 Q1
9 quarters
|
|
1310
Landstar System
LSTR
$5.74B
| $6.97M | 0.01% |
50,140
+35,300
| +238% | +$4.89M |
2022 Q1
13 quarters
|
|
1311
Immunocore
IMCR
$1.51B
| $6.97M | 0.01% |
222,052
+131,482
| +145% | +$4.08M |
2022 Q1
13 quarters
|
|
1312
Arrow Financial
AROW
$674M
| $6.92M | 0.01% |
261,805
+30,184
| +13% | +$768K |
2013 Q2
48 quarters
|
|
1313
Target Hospitality
TH
$1.8B
| $6.92M | 0.01% |
971,324
+53,300
| +6% | +$370K |
2021 Q1
17 quarters
|
|
1314
PennyMac Financial
PFSI
$3.11B
| $6.9M | 0.01% |
69,200
+33,100
| +92% | +$3.21M |
2024 Q4
2 quarters
|
|
1315
Atlanticus Holdings
ATLC
$1.42B
| $6.89M | 0.01% |
125,858
+4,200
| +3% | +$218K |
2015 Q4
38 quarters
|
|
1316
Kennametal
KMT
$2.44B
| $6.85M | 0.01% |
+298,200
| New | +$6.21M |
2025 Q2
0 quarters
|
|
1317
OraSure Technologies
OSUR
$269M
| $6.83M | 0.01% |
2,276,303
-294,840
| -11% | -$850K |
2013 Q2
48 quarters
|
|
|
PGRE
1318
DELISTED
Paramount Group
PGRE
| $6.81M | 0.01% |
1,115,800
+264,700
| +31% | +$1.38M |
2022 Q4
10 quarters
|
|
1319
Information Services Group
III
$280M
| $6.8M | 0.01% |
1,415,909
-8,900
| -0.6% | -$38.3K |
2013 Q2
48 quarters
|
|
1320
Grayscale Bitcoin Trust
GBTC
$12.3B
| $6.79M | 0.01% |
+80,100
| New | +$6.23M |
2025 Q2
0 quarters
|
|
1321
Darden Restaurants
DRI
$22.4B
| $6.78M | 0.01% |
+31,100
| New | +$6.45M |
2025 Q2
0 quarters
|
|
1322
Apogee Enterprises
APOG
$848M
| $6.73M | 0.01% |
165,683
+46,800
| +39% | +$1.93M |
2023 Q2
8 quarters
|
|
1323
Willdan Group
WLDN
$1.14B
| $6.73M | 0.01% |
107,600
-20,900
| -16% | -$997K |
2024 Q1
5 quarters
|
|
1324
Zymeworks
ZYME
$1.85B
| $6.69M | 0.01% |
533,300
+82,700
| +18% | +$985K |
2022 Q3
11 quarters
|
|
1325
Janus Henderson B-BBB CLO ETF
JBBB
$1.51B
| $6.69M | 0.01% |
138,756
-137,778
| -50% | -$6.61M |
2024 Q2
4 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.